Načítá se...

Clinical Outcomes in Carbapenem-Resistant Enterobacteriaceae Infections Treated With Ceftazidime-Avibactam: A Single-Center Observational Study

Introduction Among the several newer beta lactam+beta lactase inhibitors (BL/BLI), ceftazidime-avibactam is the only drug showing activity against OXA-48-like producers. Hence, it is being increasingly used in India to treat infections caused by carbapenem-resistant Enterobacteriaceae (CRE), especia...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cureus
Hlavní autoři: Rathish, Balram, Wilson, Arun, Warrier, Anup, Prakash, Shilpa, Babu, Rachana, Joy, Sonya
Médium: Artigo
Jazyk:Inglês
Vydáno: Cureus 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7931974/
https://ncbi.nlm.nih.gov/pubmed/33680621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13081
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!